Literature DB >> 15018983

Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.

Swati Rawat1, Sanjay K Jain.   

Abstract

Celecoxib has very low water solubility. It forms a complex with beta-cyclodextrin (betaCD) both in aqueous and in solid state. It was observed that due to formation of the inclusion complex, the solubility and dissolution rate of celecoxib were enhanced. The formation of 1:1 complex with betaCD in solution was confirmed by phase solubility and spectral shift studies. The apparent stability constants calculated by these techniques were 881.5 and 341.5 M(-1), respectively. The solid inclusion complexes of celecoxib and betaCD were prepared by the kneading method using different molar proportions of betaCD, and formation of solid inclusion complexes of celecoxib and betaCD at different molar ratios were confirmed by differential scanning calorimetry. Enhancement of dissolution rates with increasing quantity of betaCD in the complex was observed. It was also observed that the complexes exhibit higher dissolution rates than the pure drug and physical mixture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018983     DOI: 10.1016/j.ejpb.2003.10.020

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  15 in total

1.  Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization.

Authors:  Angela Lopedota; Annalisa Cutrignelli; Valentino Laquintana; Nunzio Denora; Rosa Maria Iacobazzi; Mara Perrone; Elisabetta Fanizza; Maria Mastrodonato; Donatella Mentino; Antonio Lopalco; Nicoletta Depalo; Massimo Franco
Journal:  Pharm Res       Date:  2016-05-31       Impact factor: 4.200

Review 2.  Molecular photoswitches in aqueous environments.

Authors:  Jana Volarić; Wiktor Szymanski; Nadja A Simeth; Ben L Feringa
Journal:  Chem Soc Rev       Date:  2021-11-15       Impact factor: 54.564

3.  Physicochemical properties and dissolution studies of dexamethasone acetate-beta-cyclodextrin inclusion complexes produced by different methods.

Authors:  Mayara M Doile; Keila A Fortunato; Iára C Schmücker; Sacha K Schucko; Marcos A S Silva; Patrik O Rodrigues
Journal:  AAPS PharmSciTech       Date:  2008-02-05       Impact factor: 3.246

4.  Supercritical extraction of carotenoids from Rosa canina L. hips and their formulation with beta-cyclodextrin.

Authors:  R Tozzi; N Mulinacci; K Storlikken; I Pasquali; F F Vincieri; R Bettini
Journal:  AAPS PharmSciTech       Date:  2008-06-05       Impact factor: 3.246

5.  Formulation and development of extended-release micro particulate drug delivery system of solubilized rifaximin.

Authors:  Rohan V Karanje; Yogita V Bhavsar; Kirti H Jahagirdar; Kiran S Bhise
Journal:  AAPS PharmSciTech       Date:  2013-03-21       Impact factor: 3.246

6.  Enhancement of Dissolution of Fenofibrate Using Complexation with Hydroxy Propyl β-Cyclodextrin.

Authors:  Sachin K Jagdale; Mohammad H Dehghan; Nilesh S Paul
Journal:  Turk J Pharm Sci       Date:  2018-12-31

7.  β-Cyclodextrin inclusion complex to improve physicochemical properties of pipemidic acid: characterization and bioactivity evaluation.

Authors:  Rosa Iacovino; Filomena Rapuano; Jolanda Valentina Caso; Agostino Russo; Margherita Lavorgna; Chiara Russo; Marina Isidori; Luigi Russo; Gaetano Malgieri; Carla Isernia
Journal:  Int J Mol Sci       Date:  2013-06-25       Impact factor: 5.923

8.  Effect of β-cyclodextrin complexation on solubility and enzymatic conversion of naringin.

Authors:  Li Cui; Zhen-Hai Zhang; E Sun; Xiao-Bin Jia
Journal:  Int J Mol Sci       Date:  2012-11-05       Impact factor: 5.923

9.  β-cyclodextrin assistant flavonoid glycosides enzymatic hydrolysis.

Authors:  Xin Jin; Zhen-Hai Zhang; E Sun; Xiao-Bin Jia
Journal:  Pharmacogn Mag       Date:  2013-10       Impact factor: 1.085

10.  Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems.

Authors:  P T Koh; J N Chuah; Meghna Talekar; A Gorajana; S Garg
Journal:  Indian J Pharm Sci       Date:  2013-05       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.